Legacy meets advanced therapies
The NBV Biopharma workgroup organises its annual event: Legacy meets advanced therapies.
| Program | |
| 17:15 - 18:00 | Registration, Coffee & Sandwiches Site-tour 1 |
| 18:00 - 18:05 | Opening by NBV |
| 18:05 - 18:10 | Welcome on behalf of Necstgen |
| 18:10 - 18:30 | Establishing a network to produce lentiviral vectors for Carvykti® Rutger Douma | Director MSAT Advanced Therapies | Johnson & Johnson |
| 18:30 - 18:50 | Continuous processing for monoclonal antibody purification Mariana Carvalho | PhD student | TU Delft |
| 18:50 - 19:20 | Break Site-tour 2 |
| 19:20 - 19:40 | Tumor infiltrating lymphocytes Cynthia Nijenhuis | Head Biotherapeutics facility | Netherlands Cancer Institute |
| 19:40 - 20:00 | Process development and clinical manufacturing of Cell and Gene Therapies Melissa van Pel | Head of cel therapy | Necstgen |
| 20:00 – 21:30 | Networking & Drinks |
